Sinphar Pharmaceutical Co. Ltd. - Current Ratio

The Current Ratio as of August 2026 (TTM) for Sinphar Pharmaceutical Co. Ltd. (1734.TW) is 2.37

According to Sinphar Pharmaceutical Co. Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.37. This represents a change of 33.92% compared to the average of 1.77 of the last 4 quarters.

Sinphar Pharmaceutical Co. Ltd. (1734.TW) Historical Current Ratio (quarterly & annually)

How has 1734.TW Current Ratio performed in the past?

The mean historical Current Ratio of Sinphar Pharmaceutical Co. Ltd. over the last ten years is 2.17. The current 2.37 Current Ratio has changed 10.85% with respect to the historical average. Over the past ten years (40 quarters), 1734.TW's Current Ratio was at its highest in in the December 2017 quarter at 2.65. The Current Ratio was at its lowest in in the June 2026 quarter at 0.

Sinphar Pharmaceutical Co. Ltd. (1734.TW) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sinphar Pharmaceutical Co. Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sinphar Pharmaceutical Co. Ltd. (1734.TW) Average Current Ratio

How has 1734.TW Current Ratio performed in the past?

The current Current Ratio of Sinphar Pharmaceutical Co. Ltd. (1734.TW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sinphar Pharmaceutical Co. Ltd. (1734.TW) Current Ratio vs. Peers

How is 1734.TW’s Current Ratio compared to its peers?

Sinphar Pharmaceutical Co. Ltd.’s Current Ratio is less than OBI Pharma, Inc. (3.70), greater than Panion & Bf Biotech Inc. (1.32), less than Savior Lifetec Corp. (6.23), greater than Hi-Clearance Inc. (1.78), less than TaiGen Biopharmaceuticals Holdings Limited (19.34), less than Pharmosa Biopharm Inc. (12.45), less than Locus Cell Co., Ltd. (0), greater than Pacific Hospital Supply Co., Ltd (2.35), greater than Mycenax Biotech Inc. (0.43), less than BioGend Therapeutics Co., Ltd. (32.13),

Build a custom stock screener for Sinphar Pharmaceutical Co. Ltd. (1734.TW) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sinphar Pharmaceutical Co. Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sinphar Pharmaceutical Co. Ltd. (1734.TW) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sinphar Pharmaceutical Co. Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.